Physician profile
William Brian Bailey
NPI 1861497349
$2,821.67
in general payments reported to CMS, 2019-2025
22 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $361 · 2021: $369 · 2022: $407 · 2023: $511 · 2024: $486 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $501.32 | 2019-2024 | Aveir |
| Boston Scientific Corporation | $388.49 | 2019-2024 | Rotapro, Wolverine Coronary Cutting Balloon, Opticross |
| Lantheus Medical Imaging, INC. | $309.38 | 2019-2025 | Definity |
| Amgen INC. | $195.53 | 2019-2022 | |
| Medtronic, INC. | $152.73 | 2022-2025 | Pulseselect, Affera Mapping System |
| Novartis Pharmaceuticals Corporation | $135.58 | 2019-2023 | |
| Edwards Lifesciences Corporation | $134.65 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Livanova USA, INC. | $131.75 | 2023 | Lifesparc |
| Pfizer INC. | $118.52 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $106.27 | 2021-2024 | Farxiga |
| Daxor Corporation | $92.59 | 2024 | Bva-100 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.21 | 2021 | |
| Janssen Pharmaceuticals, INC | $85.59 | 2019-2022 | |
| Abiomed | $85.37 | 2023-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $79.89 | 2023 | Camzyos |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $76.44 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Astellas Pharma US INC | $33.39 | 2019-2022 | |
| Corindus INC. | $26.25 | 2019 | |
| Heartflow, INC. | $26.18 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.92 | 2023 | Lifevest |
| Otsuka America Pharmaceutical, INC. | $18.12 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.